NUtech Ventures/UTDC uses proof of concept funding to support a promising imaging spin-out, Ground Fluor Pharmaceuticals Inc.
University Technology Development Corp. provided proof-of-concept funding to help move DiMagno’s imaging agents out of the lab and into clinical trials. Supporting the transfer of university technology to the marketplace, UTDC is a University of Nebraska affiliate and the parent company of NUtech Ventures.